CD73 targeted combination therapy reverses PD-1 inhibitor resistance in CD73-high PD-L1-negative NSCLC: Evidence from pleural effusion organoids

Global Medical Genetics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles